Important note
This AI stock analysis for hims is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!
hims - AI Stock Analysis
Analysis generated June 23, 2025
Hims & Hers Health, Inc. (listed as Hims on the stock exchange) is a telehealth company that offers a range of wellness and healthcare services primarily via online platforms. Known for its direct-to-consumer approach, the company focuses on dermatology, mental health, and primary care, among other sectors. Hims aims to democratize access to healthcare by offering affordable alternatives to traditional healthcare services.
Fundamental Analysis
Revenue for the last quarter was $586M. This represents a significant increase of 21.80% compared to the previous quarter, indicating robust quarterly growth. Additionally, there is an impressive year-over-year growth of 110.67%, suggesting a highly positive long-term outlook in terms of revenue generation.
Net income for the last quarter was $49M, up 90.14% from the previous quarter, demonstrating notable profitability improvements. Year-over-year, the increase is a staggering 344.69%, signifying significant growth in net income which may attract long-term investors.
EBITDA for the last quarter stands at $58M, reflecting a remarkable increase of 134.81% compared to the previous quarter. Year-over-year growth in EBITDA is an extraordinary 348.67%, highlighting substantial improvements in operational efficiency and profitability.
The current Price-to-Earnings (P/E) ratio is 94.44. While high P/E ratios can often indicate growth expectations, this figure might indicate potential overvaluation and thus a bearish signal.
Notably, there has been some insider selling recently, which could be interpreted as a bearish signal. Insider sales can often indicate a lack of confidence in the company's short-term performance.
Technical Analysis
Today's stock price for Hims is $45.92. This represents a decline of 16.25% compared to a month ago, which may raise concerns about short-term performance. However, the stock price has increased by 107.31% compared to a year ago, highlighting a positive long-term trend.
The current Simple Moving Average (SMA10) is $59.07, which is lower than the previous SMA10 of $60.03. This suggests a bearish trend in price movement. Additionally, the Relative Strength Index (RSI) is 38.4, indicating a neutral condition but leaning towards the lower end, which might suggest near-term caution.
Alternative Data Analysis
Starting with job postings and employee sentiment, Hims has 92 open positions, which is up by 53% in the last couple of months. This indicates a company looking to expand and grow, which is generally a healthy sign. However, employee sentiment about the business outlook has dropped by 17% in recent months, which could be worrisome.
Regarding customer acquisition, Hims has an estimated 660,000 visitors to their webpage, up by 300% recently. This bullish trend can indicate a substantial increase in potential customers. Furthermore, Hims has approximately 1,700 daily app downloads, which remains steady.
In terms of customer engagement, Hims has 220,000 followers on Instagram, a 3% increase over the last couple of months. Additionally, there is a 17% increase in Twitter followers, now totaling 24,000. These metrics suggest growing interest and higher engagement with the company's brand.
According to AltIndex's AI score, which incorporates fundamental, technical, and alternative data, Hims has an AI score of 54. This indicates a hold signal based on current metrics.
Conclusion and Recommendation
Based on the analysis across fundamental, technical, and alternative data, Hims & Hers Health, Inc. shows strong fundamental growth, particularly in revenue, net income, and EBITDA. However, the high P/E ratio and recent insider selling provide reasons for caution. The technical analysis shows a concerning short-term trend, yet a robust long-term outlook. Additionally, the company’s expansion efforts and increasing customer engagement are healthy indicative signs, though declining employee sentiment is something to monitor.
Considering all the factors, a balanced approach could be to hold the stock for now, keeping an eye on both quarterly performance and broader market conditions. This strategy allows the investor to benefit from any future growth while minimizing exposure to potential short-term volatility.
Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.
